Io Therapeutics presents today at the American Society for Hematology Annual Meeting, preclinical studies demonstrating combination treatment with BCMA CAR-T cells plus the company's RXR agonist compound IRX4204 has synergistic efficacy against human mul 6-12-2025, 20:05

Bombardier Leads Industry-Wide Sustainability Efforts with Landmark Environmental Product Declarations for Global 5500 and Global 6500 Aircraft 2-05-2023, 18:45

Sagtec Global (NASDAQ: SAGT) Accelerates Middle East Expansion with US$10 Million Smart Hospitality Tech Deal in UAE 1-07-2025, 19:46